Ausgabe 6/2006
Inhalt (9 Artikel)
Leading Article
Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy
Cornelis Boersma, Jarir Atthobari, Ron T. Gansevoort, Lolkje T. W. de Jong-Van den Berg, Paul E. de Jong, Dick de Zeeuw, Lieven J. P. Annemans, Maarten J. Postma
Original Research Article
The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
George W. Carides, Shahnaz Shahinfar, Erik J. Dasbach, William F. Keane, William C. Gerth, Charles M. Alexander, William H. Herman, Barry M. Brenner
Original Research Article
The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status
Jarmo Hahl, Helena Hämäläinen, Tuula Simell, Olli Simell
Original Research Article
Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients
Peter K. Schädlich, Michael Kentsch, Manfred Weber, Wolfgang Kämmerer, Josef Georg Brecht, Vijay Nadipelli, Eduard Huppertz
Original Research Article
Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients
George Dranitsaris, Mark Vincent, Mark Crowther
Original Research Article
Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?
Lee-Yee Chong, Oh-Moh Chay, Li Shu-Chuen
Correspondence
Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer’s Disease
Nick Bosanquet, Andrew Yeates
Correspondence
The Authors’ Reply
Colin Green, Joanna Picot, Emma Loveman, Andrea Takeda, Jo Kirby, Andrew Clegg